NuGenea
Pre-clinical- Indications
- Inflammatory diseases
Company intelligence / Profile preview
Genetics Institute of America provides CAP Accredited and CLIA Certified advanced molecular diagnostics with a focus on hereditary and somatic cancer risk assessment. The company has expanded its laboratory space to enhance RNA research capabilities and supports both clinical decision-making and pharmaceutical development through partnerships such as the OneCellDx OncoPredikt HRD assay. Their services are available to clients across forty-six states.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genetics Institute of America.